Clyde E. Markowitz, MD, is an assistant professor of neurology at the University of Pennsylvania School of Medicine in Philadelphia. He is an attending neurologist and co-director of the MS Center at the Hospital of the University of Pennsylvania. Dr. Markowitz earned his BS in business administration and marketing at the State University of New York at Buffalo. He participated in a post-baccalaureate pre-medical program at Columbia University, and he later earned his MD from the Columbia University College of Physicians and Surgeons. He also completed his internship, residency and postdoctoral research and clinical fellowship at the Columbia Presbyterian Medical Center. Dr. Markowitz is a member of the American Academy of Neurology, the Association for Research in Nervous and Mental Disease and the American Association for the Advancement of Science. He also serves on the professional advisory committee for his local chapter of the National Multiple Sclerosis Society. Dr. Markowitz is the author and co-author of a number of publications, and he serves as an ad hoc reviewer for Multiple Sclerosis, Neuro-Rehabilitation, Neural Repair and The Consultant.
Dr. Markowitz is a clinical investigator in the TERMS Phase IIb clinical study of Tovaxin. Dr. Markowitz is reimbursed by Opexa for his service in this capacity.